Security key
71722W107
Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT)
CUSIP: 71722W107
Q3 2021 13F Holders as of 30 Sep 2021
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 25,543,470
- Total 13F value
- $819,833,454
- Share change
- +624,562
- SEC-reported price per share
- $32.10
- Number of holders
- 81
- Value change
- +$19,152,056
- Number of buys
- 32
- Number of sells
- 29
- Shares outstanding
- 78,837,943
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2021
Institutions
81
Top holders
10
PHAT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2021
Previous quarter: Q2 2021
Phathom Pharmaceuticals, Inc. SEC filings
Phathom Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 71722W107
Recent filing periods:
Ownership snapshot
Top reported holders of PHAT - Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FRAZIER MANAGEMENT LLC
Disclosed value leader
FRAZIER MANAGEMENT LLC
Comparable rows
15/15
Latest evidence
30 Jun 2021
13F
Lead comparable stake: 7.4%
Showing 1-6 of 15 holder rows.
Quick read
FRAZIER MANAGEMENT LLC leads the comparable SEC ownership view at 7.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FRAZIER MANAGEMENT LLC's linked filing trail.
Comparable ownership
Top 5
FRAZIER MANAGEMENT LLC
7.4%
RA CAPITAL MANAGEMENT, L.P.
4%
Medicxi Ventures Management (Jers...
2.6%
Invesco Ltd.
2.6%
JANUS HENDERSON GROUP PLC
2.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FRAZIER MANAGEMENT LLC |
13F
Company
|
7.4%
|
$197,258,000
5,827,415 shares
|
— | 30 Jun 2021 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
4%
|
$105,443,000
3,115,008 shares
|
— | 30 Jun 2021 |
| Medicxi Ventures Management (Jersey) Ltd |
13F
Company
|
2.6%
|
$69,997,000
2,067,861 shares
|
— | 30 Jun 2021 |
| Invesco Ltd. |
13F
Company
|
2.6%
|
$68,424,000
2,021,400 shares
|
— | 30 Jun 2021 |
| JANUS HENDERSON GROUP PLC |
13F
Company
|
2.5%
|
$66,067,000
1,951,634 shares
|
— | 30 Jun 2021 |
| VANGUARD GROUP INC |
13F
Company
|
2%
|
$52,783,000
1,559,289 shares
|
— | 30 Jun 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
81
Shares
25,543,470
Rows available
81
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
76
Q3 2021 holders
81
Holder diff
5
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 value | Q3 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend